IMAX Corporation announced on March 31, 2026, that its Chief Executive Officer, Richard Gelfond, is taking a temporary medical leave of absence. Gelfond is currently undergoing treatment for pneumonia. According to a statement released by the company, the CEO is already making steady progress in his recovery, but he will be stepping away from his daily responsibilities to focus on his health.

During Gelfond's absence, IMAX will be managed by a senior executive team that will oversee day-to-day operations. This internal leadership group is set to work in close coordination with Darren Throop, the Chairman of the IMAX Board of Directors. The company confirmed that this structure is designed to maintain business continuity across its global network of large-format theaters.

The announcement was made to ensure full transparency for shareholders and industry partners. By disclosing Gelfond's status now, the company aims to prevent speculation regarding his absence from upcoming high-profile events and scheduled corporate meetings. Gelfond has served as the CEO of IMAX since 2009 and has been a driving force behind the company’s expansion into major international markets and blockbuster film partnerships.